Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 7, 2020 and accepted by EDGAR at Aug 7, 2020, 09:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$1.0kus-gaap:Revenues
Revenue6 months2020-01-01 to 2020-06-30$22.0kus-gaap:Revenues
Research and development3 months2020-04-01 to 2020-06-30$13.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$26.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-04-01 to 2020-06-30$6.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-30$11.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-01 to 2020-06-30−$20.2mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$38.8mus-gaap:OperatingIncomeLoss
Income tax3 months2020-04-01 to 2020-06-30$4.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-01 to 2020-06-30$4.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-01 to 2020-06-30−$20.1mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30−$38.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30−$0.20us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30−$0.39us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2020-01-01 to 2020-06-30−$29.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$540.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2020-01-01 to 2020-06-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-06-30$102.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$115.3mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$196.2mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$17.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$26.5mus-gaap:Liabilities
Shareholders' equityAt period end2020-06-30$169.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-038096. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.